Literature DB >> 10219834

Eliminating the need for dietary restrictions when using a sensitive guaiac fecal occult blood test.

P Rozen1, J Knaani, Z Samuel.   

Abstract

When using the peroxidase-sensitive guaiac fecal occult blood test, Hemoccult Sensa (HOS), dietary restrictions are recommended so as to reduce its false positivity from ingested peroxidases. As dietary restrictions could reduce compliance for annual retesting, we reexamined their need. HOS was given to 944 persons in an endoscopic screening/follow-up program. Only the first 403 received instructions regarding a low peroxidase-containing diet for three days before and during HOS collection. Development was delayed 3-14 days after HOS preparation, and there were no significant differences in duration before HOS development in examinees with or without colorectal neoplasia and having or not having a positive test. Of the 901 persons without endoscopic evidence of neoplasia, 377 had received and 524 had not received instructions on dietary restrictions. Their HOS positivity was 7.2% and 5.5%, respectively (P = 0.26). When using HOS, delaying development by 3-14 days allows breakdown of ingested peroxidases, so dietary restrictions are not needed in our population, which has a low red meat intake.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10219834     DOI: 10.1023/a:1026618010312

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  12 in total

1.  Interference of plant peroxidases with guaiac-based fecal occult blood tests is avoidable.

Authors:  M A Sinatra; D J St John; G P Young
Journal:  Clin Chem       Date:  1999-01       Impact factor: 8.327

2.  Colorectal cancer screening in Israel.

Authors:  P Rozen
Journal:  Gastrointest Endosc       Date:  1998-01       Impact factor: 9.427

Review 3.  Screening for colorectal cancer with the fecal occult blood test: a background paper. American College of Physicians.

Authors:  D F Ransohoff; C A Lang
Journal:  Ann Intern Med       Date:  1997-05-15       Impact factor: 25.391

4.  Immunochemical versus guaiac occult blood stool tests: results of a community-based screening program.

Authors:  N Petrelli; A M Michalek; A Freedman; M Baroni; I Mink; M Rodriguez-Bigas
Journal:  Surg Oncol       Date:  1994-02       Impact factor: 3.279

5.  Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.

Authors:  J D Hardcastle; J O Chamberlain; M H Robinson; S M Moss; S S Amar; T W Balfour; P D James; C M Mangham
Journal:  Lancet       Date:  1996-11-30       Impact factor: 79.321

6.  Randomised study of screening for colorectal cancer with faecal-occult-blood test.

Authors:  O Kronborg; C Fenger; J Olsen; O D Jørgensen; O Søndergaard
Journal:  Lancet       Date:  1996-11-30       Impact factor: 79.321

7.  Readability and sensitivity of a new faecal occult blood test in a hospital ward environment. Comparison with an established test.

Authors:  M T Petty; M C Deacon; M A Alexeyeff; D J St John; G P Young
Journal:  Med J Aust       Date:  1992-03-16       Impact factor: 7.738

8.  Performance characteristics and comparison of two immunochemical and two guaiac fecal occult blood screening tests for colorectal neoplasia.

Authors:  P Rozen; J Knaani; Z Samuel
Journal:  Dig Dis Sci       Date:  1997-10       Impact factor: 3.199

9.  Evaluation and comparison of an immunochemical and a guaiac faecal occult blood screening test for colorectal neoplasia.

Authors:  P Rozen; J Knaani; N Papo
Journal:  Eur J Cancer Prev       Date:  1995-12       Impact factor: 2.497

10.  Evaluation of new occult blood tests for detection of colorectal neoplasia.

Authors:  D J St John; G P Young; M A Alexeyeff; M C Deacon; A M Cuthbertson; F A Macrae; J C Penfold
Journal:  Gastroenterology       Date:  1993-06       Impact factor: 22.682

View more
  2 in total

Review 1.  Dietary interventions for fecal occult blood test screening: systematic review of the literature.

Authors:  Gerald Konrad
Journal:  Can Fam Physician       Date:  2010-03       Impact factor: 3.275

2.  Detection of colorectal cancer in symptomatic outpatients without visible rectal bleeding: Validity of the fecal occult blood test.

Authors:  Niels Christian Bjerregaard; Anders Tøttrup; Henrik Toft Sørensen; Søren Laurberg
Journal:  Clin Epidemiol       Date:  2009-08-09       Impact factor: 4.790

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.